LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 82 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,440,419 | $102,697,000 | 37.12% |
| RTW INVESTMENTS, LP | 1,028,929 | $30,714,000 | 8.08% |
| Consonance Capital Management LP | 1,420,742 | $42,409,000 | 4.44% |
| Perceptive Advisors | 2,139,274 | $63,857,000 | 3.64% |
| Broadfin Capital, LLC | 782,887 | $23,369,000 | 2.83% |
| Crawford Lake Capital Management, LLC | 171,373 | $5,115,000 | 2.03% |
| Crawford Lake Capital Management, LLC | 162,600 | $4,380,000 | 1.74% |
| ISZO CAPITAL MANAGEMENT LP | 30,967 | $924,000 | 1.61% |
| FT Options LLC | 33,141 | $989,000 | 1.30% |
| Monashee Investment Management LLC | 100,000 | $2,985,000 | 1.20% |